Pasello G, Lorenzi M, Scattolin D, Del Conte A, et al. Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World. Oncologist 2024 Mar 23:oyae043. doi: 10.1093.
PMID: 38520745